Daily use of talcum powder for over 30 years has resulted in a case of ovarian cancer, alleges a new lawsuit filed against Johnson & Johnson and Imerys Talc America. The plaintiff, Rebecca Lichtenfels, filed her product liability lawsuit in the U.S. District Court for the District of Columbia on... Read more »

A resident of Delaware claims that the popular shingles vaccine, Zostavax, caused him to develop severe problems with his eyes and vision. Leroy Crawley filed his product liability lawsuit on January 3, 2019 in the U.S. District Court for the Eastern District of Pennsylvania, where it joins other Zostavax lawsuits... Read more »

A motion was recently filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) that seeks to consolidate federal complaints filed with regard to valsartan, a generic hypertension drug. The motion was filed late in October 2018 by Robert Kruk on behalf of himself and other plaintiffs with pending valsartan lawsuits. Kruk... Read more »

There are more than 10,000 talc powder lawsuits pending against Johnson & Johnson. Most of them are pending in the multidistrict litigation (MDL) in federal court, and the rest are pending in state courts around the country. The product liability lawsuits raise similar claims: That Johnson & Johnson’s Baby Powder... Read more »

The U.S. Food and Drug Administration (FDA) recently issued a new safety alert regarding the increased risk of Fournier’s gangrene among diabetes patients using Invokana and other drugs in the same class. Fournier’s gangrene is considered to be a rare, but very serious complication of SGLT2 inhibitors. This condition is... Read more »

Hundreds of testosterone lawsuits have been officially resolved now that the master settlement agreement has been finalized, as of late July 2018. The settlement agreement only applies to Androderm lawsuits filed against Actavis and Allergan. Thousands of other testosterone lawsuits have been filed against other manufacturers in recent years. This... Read more »

Actavis, the makers of Androderm, has announced that there is a tentative settlement agreement in place that would resolve roughly 500 lawsuits. The plaintiffs involved with the litigation allege that they suffered serious complications as a result of their use of the defendants’ medicated testosterone patch. Actavis, which was acquired... Read more »

Twenty-two women who developed ovarian cancer that they claim was caused by Johnson & Johnson’s talcum powder products will have their day in court soon. Jury selection for the state court trial is set to begin this week. The trial is expected to last about six weeks. During the trial,... Read more »

Plaintiffs who have filed product liability lawsuits against the manufacturers of popular proton pump inhibitors have requested that the judge schedule trial dates. The lawsuits were filed after plaintiffs claimed they sustained complications, including kidney injuries, after taking PPIs like Nexium, Prilosec, Prevacid, and Protonix. About 4,200 lawsuits have been... Read more »

A jury in New Jersey awarded a couple $117 million dollars following arguments that the defendant’s product resulted in the plaintiff’s diagnosis of mesothelioma, a type of cancer. Other juries have found the talc powder manufacturer liable in cases in which the plaintiffs allege the Shower to Shower powder caused... Read more »

Sign Up for Lawsuit Updates

Email

This field is required.

About Drug Reporter

DrugReporter.com provides up to date information on lawsuits involving dangerous drugs that affect consumers throughout the country. This website is sponsored by Eisbrouch Marsh, LLC, a national law firm with principal offices located at 50 Main Street Hackensack, NJ 07601. The information found here is not legal advice. Visitors should retain legal counsel before making legal decisions. If you believe certain facts contained herein are in error, please contact the webmaster.

This website contains attorney advertising.The material posted here is not intended to create nor does it constitute, a lawyer-client relationship. Visitors to the site should not act upon information here without first seeking professional counsel. Prior results do not guarantee a similar outcome in future cases.